SCHEMBL27228264

SCHEMBL27228264

Cc1ccc2c(n1)C(C)(C)CN2C(=O)[C@@H]1CN(Cc2ccccc2)C[C@H]1C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ UBE2M P61081 1/20 0.37
▸ DCUN1D1 Q96GG9 1/20 0.37
▸ MEN1 O00255 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ S1PR5 Q9H228 2/20 0.36
▸ S1PR1 P21453 1/20 0.36
▸ AMPD2 Q01433 2/20 0.35
▸ USP30 Q70CQ3 1/20 0.35
▸ PDE9A O76083 2/20 0.35
▸ CHRM2 P08172 1/20 0.35
▸ CHRM1 P11229 1/20 0.35
▸ CHRM3 P20309 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ CACNA1G O43497 1/20 0.35
▸ CACNA1H O95180 1/20 0.35
▸ CACNA1I Q9P0X4 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ BRD4 O60885 1/20 0.35
▸ DPP4 P27487 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27228263 1.00 UBE2M (0.37) UBE2MDCUN1D1MEN1LMNAKMT2A
SCHEMBL27228337 0.89 S1PR5 (0.43) MEN1LMNAKMT2AS1PR5S1PR1
SCHEMBL27228388 0.83 FAAH (0.50) MEN1LMNAKMT2AALDH1A1CHRM4
SCHEMBL27228408 0.82 GRIN2B (0.39) S1PR5S1PR1AMPD2
SCHEMBL27228328 0.80 MAPK1 (0.41) ALDH1A1CACNA1GCACNA1HCACNA1ICHRM4
SCHEMBL27228277 0.79 XIAP (0.41) MEN1KMT2AS1PR5S1PR1XIAP
SCHEMBL27228647 0.78 AVPR1A (0.46) MEN1LMNAKMT2AALDH1A1
SCHEMBL27232294 0.78 DRD4 (0.48) —
SCHEMBL31016693 0.78 ALDH1A1 (0.42) MEN1LMNAKMT2AS1PR1ALDH1A1
SCHEMBL27228338 0.78 CYP2D6 (0.40) MEN1KMT2AAMPD2ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174671-A1 New 2,3-Dihydro-1H-pyrrolo[3,2-b]pyridine Derivatives as Sigma Ligands ACONDICIONAMIENTO TARRASENSE (ES) 2024-05-30 — — US claimed
US-20240174671-A1 New 2,3-Dihydro-1H-pyrrolo[3,2-b]pyridine Derivatives as Sigma Ligands ACONDICIONAMIENTO TARRASENSE (ES) 2024-05-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240174671-A1 New 2,3-Dihydro-1H-pyrrolo[3,2-b]pyridine Derivatives as Sigma Ligands SIGMAR1, OPRD1, TMEM97 UBE2M 4476/4885DCUN1D1 3137/4885MEN1 4826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback